Home / Business and Economy / PepsiCo Faces Snack and Drink Threat
PepsiCo Faces Snack and Drink Threat
7 Oct
Summary
- PepsiCo faces pressure from activist investors and new weight-loss drugs.
- North American business volumes have declined amid rising costs.
- Company introduced healthier options but faces valuation gap concerns.
PepsiCo is currently navigating significant challenges in achieving its set growth and margin targets. Mounting pressure from activist investor Elliott Investment Management, which acquired a substantial stake, is compelling the company to enhance its performance, particularly in its North American operations.
The company's North America business has experienced a notable decline in sales volumes and market share. This downturn is attributed to increased input costs, exacerbated by global events, and persistent inflation that dampens consumer demand. PepsiCo is also contending with the growing influence of GLP-1 weight-loss drugs, which pose a potential threat to its core snack and beverage offerings.
In an effort to adapt, PepsiCo announced in December 2025 plans to reduce its US product range and improve its core operating margin. Despite these initiatives, its core operating margin saw a slight decrease in the first half of 2026 compared to the previous year. The company has also introduced healthier product alternatives, such as Doritos Protein and SunChips Fiber, in response to evolving consumer preferences.
Analysts are observing PepsiCo's strategic moves with a mix of anticipation and concern. While modest revenue growth is predicted, questions persist about the long-term effectiveness of its recovery strategy and its ability to close a widening valuation gap with competitors like Coca-Cola. The company's shares have seen a decline since Elliott's investment, underscoring the investor sentiment.
